相关实验视频
Updated: May 2, 2026

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.1K
索尔提林作为动脉样硬化斑块进展的罪祸首:临床和实验研究的证据
Guangyu Cheng1, Jie Liu2, HongLi Zhang2
1The Sixth Department of acupuncture and moxibustion, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, China.
Current molecular medicine
|January 23, 2025
概括
索尔提林是一种参与脂质运输的受体,对动脉样硬化斑块的进展有显著的贡献. 本综述总结了将索尔提林与心血管疾病风险和潜在机制联系在一起的证据.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 脂质代谢 脂质代谢是什么
背景情况:
- 索尔提林作为各种分子的受体,包括脂质和生长因子.
- 索尔提林在细胞外囊泡介导的运输中发挥作用.
- 越来越多的证据表明,利林与高脂血症和动脉样硬化发展有关.
研究的目的:
- 综合审查sortilin对动脉样硬化进展的贡献.
- 总结关于sortilin在动脉样硬化中的作用的实验和临床发现.
- 阐明索尔蒂林影响动脉样硬化的潜在机制.
主要方法:
- 实验研究的文献评论.
- 对流行病学和临床证据的分析.
- 关于sortilin分子功能和疾病关联的研究结果的综合.
主要成果:
- 索尔提林涉及脂质和其他异位原因的运输.
- 流行病学数据将sortilin与患者的动脉样硬化斑块进展联系起来.
- 索尔提林在细胞外囊泡功能中的作用可能有助于疾病的发病.
结论:
- 索尔提林是动脉样硬化的进展的一个关键因素.
- 了解索尔蒂林的机制为心血管疾病提供了潜在的治疗点.
- 需要进一步的研究,以充分阐明索尔提林在动脉样硬化中的多方面的作用.
相关概念视频
Inflammation
46.6K
Overview
46.6K
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741

